BioSpace News Archive

Significant rise in chronic diseases along with the rise of infectious diseases has led the demand in the global capillary blood collection devices market.

The point-of-care diagnostics has made giants strides in the global healthcare industry in recent years.

10 Clinical Posters and Video Presentations Highlight the Breadth of Clinical Benefits of the MolecuLight Device for Wound Care Practitioners

Encouraging Data from FORWARD II Study of Mirvetuximab in Combination with Avastin® in Recurrent Ovarian Cancer, Regardless of Platinum Status, Presented at ASCO

Myriad Genetics, Inc., a leader in molecular diagnostics and precision medicine, announced that Medicare has expanded coverage for BRACAnalysis® CDx for men with prostate cancer who are eligible or may become eligible for treatment Lynparza®.

RHB-204 is a potential first-line oral treatment for pulmonary nontuberculous mycobacteria (NTM) infections, a rare disease with no FDA-approved first-line therapy

Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, is pleased to announce that it has submitted a patent application for the potential use of nasally administered Foralumab, a fully human anti-CD3 monoclonal antibody, for the treatment of COVID-19 either alone or in combination with other anti-viral drugs.

Artificial tears are referred to as lubricants eye drops that are used for treating the irritation and dryness associated with the deficiency in tear production in dry eyes or keratoconjunctivitis sicca.

Iron is one of the most significant minerals required for the correct working of human bodies.

BioNTech and Regeneron plan to jointly conduct a randomized Phase 2 study combining BNT111 FixVac and Libtayo for the treatment of melanoma that has progressed after prior PD-1 blockade